Traws Pharma Adds John Leaman, MD, as Independent Director and Formalizes Appointments of Two Key Executives

"We believe Dr. Leaman’s insights and guidance will be invaluable as we prepare to enroll subjects in Phase 2 studies ...

Bispecific inhibitor can combat a wide range of coronaviruses, including Paxlovid-resistant variants

A team of researchers have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic ...
TMCnet

Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Enanta intends to use the net proceeds from this offering, together with its existing cash, cash equivalents and short-term and long-term investments, to fund its clinical trials, research, and ...

NUCLIDIUM Receives Notice of Allowance for Composition-of-Matter Patent Covering FAP inhibitor-based Radiodiagnostics and Therapeutics in the United States

NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, today announced that it has received a Notice of Allowance from the U.S. Patent ...